Novel near-point-of-care TB molecular tests: navigating the repercussions of sensitivity tradeoffs
The International Journal of Tuberculosis and Lung Disease · 2026
DOI: 10.5588/ijtld.25.0793 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, 2026. Verfasst von E A Kendall. Hauptthemen laut MEDLINE: Point-of-Care Systems, Molecular Diagnostic Techniques, Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
New near-point-of-care, swab-based molecular tests for TB offer substantial operational advantages including improved accessibility and cost. However, early data suggest some loss of sensitivity: in particular, these tests tend to miss the lowest-positive molecular signals, such as ‘trace’ Xpert MTB/RIF Ultra sputum test results. Recent cohort studies suggest most trace signals represent TB disease, even if not currently confirmable by culture. However, the underdiagnosis arising from reduced sensitivity will be greatest in populations with mild disease, where immediate clinical and transmission risks may be lowest and benefits of expanded access may be greatest. Altered test characteristics may also alter empiric TB treatment practices, with variable effects on over-diagnosis. The improved access and yield offered by near-point-of-care platforms and swab specimens are likely to justify these tradeoffs, more than offsetting detrimental effects on case detection in most contexts. Implementation strategies are proposed to mitigate potential harms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Kendall, E. A. (2026). Novel near-point-of-care TB molecular tests: navigating the repercussions of sensitivity tradeoffs. The International Journal of Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.25.0793
Vancouver
Kendall EA. Novel near-point-of-care TB molecular tests: navigating the repercussions of sensitivity tradeoffs. The International Journal of Tuberculosis and Lung Disease. 2026. doi:10.5588/ijtld.25.0793
BibTeX
@article{Kendall2026,
author = {Kendall, E A},
title = {Novel near-point-of-care TB molecular tests: navigating the repercussions of sensitivity tradeoffs},
journal = {The International Journal of Tuberculosis and Lung Disease},
year = {2026},
doi = {10.5588/ijtld.25.0793}
}
EUVIMED